Tribute Pharmaceuticals Canada Inc. — Form D/A

Tribute Pharmaceuticals Canada Inc. of Milton, A6, a company, filed a Form D amendment with the SEC on 2015-06-10. The offering totals $808K. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Steven H GoldmanDirectorMilton, A6
John M GregoryDirectorMilton, A6
Robert M HarrisDirectorMilton, A6
John J KimeDirectorMilton, A6
Scott J LangilleDirectorMilton, A6
Arnold J TenneyDirectorMilton, A6
F Martin ThrasherDirectorMilton, A6
Janice M ClarkeExecutive OfficerLondon, A6
Robert M HarrisExecutive OfficerMilton, A6
Scott J LangilleExecutive OfficerMilton, A6
Robert HarrisDirectorPotomac, MD
Robert HarrisExecutive OfficerPotomac, MD
Eric L TrachtenbergDirectorWatertown, MA
Andrew I KovenDirectorBoston, MA
Andrew I KovenExecutive OfficerBoston, MA
Scott J CharlesDirectorVancouver, A1
Murray I RoachExecutive OfficerMilton, A6
Bernard I ChiassonExecutive OfficerMilton, A6
Robert L HarrisDirectorDallas, TX
F. Martin ThrasherDirectorMilton, A6
Robert H HarrisDirectorMilton, A6
Robert H HarrisExecutive OfficerMilton, A6
Robert H GregoryDirectorMilton, A6
John M KimeDirectorMilton, A6
Scott Martin LangilleDirectorMilton, A6

Other filings by this issuer (7)

FiledFormOfferingSold
2016-02-05D$75.0M$75.0M
2016-02-05D$75.0M$75.0M
2015-06-05D$4.1M$4.1M
2014-10-21D$276K
2014-10-21D$6.6M
2014-10-21D$1.1M
2013-03-18D$4.3M$4.3M

More